Cipla shares fall 7% after Pithampur unit gets 8 observations from USFDA
The US Food and Drug Administration (USFDA) conducted a current Good Manufacturing Practices (cGMP) inspection at the manufacturing facility from February 6-17, the Mumbai-based drug firm said in a regulatory filing on Saturday.
from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/MagYAso
>
from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/MagYAso
>
Comments
Post a Comment
please do not enter any spam link in the comment box.